Long-term data from the PARTNER 2 trial showed a trend towards a lower rate of all-cause death/disabling stroke in the SAVR group.[ 24 ] Similarly, although the TAVR group had fewer primary endpoint events than the SAVR group at the 2-year follow-up, the TAVR group had more deaths, strokes, and valve thrombosis events from 1 to 2 years.[ 29 ] In addition, a lack of consistent commissural alignment with TAVR may affect durability as well as future coronary access and redo TAVR.[ 30 ] A more important issue with TAVR durability has arisen in the context of failed TAVR.
← all excerpts
Transcatheter Versus Surgical Aortic Valve Replacement in Young, Low-risk Patients with Severe Aortic Stenosis.
1
—
—